JPS5679626A - Semi-solid medicine - Google Patents

Semi-solid medicine

Info

Publication number
JPS5679626A
JPS5679626A JP15561679A JP15561679A JPS5679626A JP S5679626 A JPS5679626 A JP S5679626A JP 15561679 A JP15561679 A JP 15561679A JP 15561679 A JP15561679 A JP 15561679A JP S5679626 A JPS5679626 A JP S5679626A
Authority
JP
Japan
Prior art keywords
semi
oily component
solid medicine
hydrophilic
starch sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15561679A
Other languages
Japanese (ja)
Inventor
Takehito Tabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIHON SURFACTANT KOGYO KK
NIPPON SAAFUAKUTANTO KOGYO KK
Original Assignee
NIHON SURFACTANT KOGYO KK
NIPPON SAAFUAKUTANTO KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIHON SURFACTANT KOGYO KK, NIPPON SAAFUAKUTANTO KOGYO KK filed Critical NIHON SURFACTANT KOGYO KK
Priority to JP15561679A priority Critical patent/JPS5679626A/en
Publication of JPS5679626A publication Critical patent/JPS5679626A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To prepare a semi-solid medicine capable of dissolving both hydrophilic drug and olephilic drug, by using a gel composition obtained by adding a polyhydric alcohol and an oily component to a sugar fatty acid ester, as a base.
CONSTITUTION: A semi-solid medicine for ointment, eye ointment, poultice, plaster and suppository use, is prepared by using a base comprising a gel composition composed of (A) one or more hydrophilic esters derived from sucrose, lactose, maltose, lactitol, maltitol, starch sugar or reduced starch sugar and a fatty acid (e.g. starch sugar lauric acid ester), (B) a polyhydric alcohol (e.g. glycerine, propylene glycol, etc.) and (C) an oily component (e.g. vaseline). The addition of the oily component enables the inclusion of oleophilic drugs as well as hydrophilic drugs in high efficiency.
COPYRIGHT: (C)1981,JPO&Japio
JP15561679A 1979-12-03 1979-12-03 Semi-solid medicine Pending JPS5679626A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15561679A JPS5679626A (en) 1979-12-03 1979-12-03 Semi-solid medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15561679A JPS5679626A (en) 1979-12-03 1979-12-03 Semi-solid medicine

Publications (1)

Publication Number Publication Date
JPS5679626A true JPS5679626A (en) 1981-06-30

Family

ID=15609900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15561679A Pending JPS5679626A (en) 1979-12-03 1979-12-03 Semi-solid medicine

Country Status (1)

Country Link
JP (1) JPS5679626A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63227521A (en) * 1987-02-26 1988-09-21 アルザ・コーポレーション Skin penetration accelerator composition using sucrose ester

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4947520A (en) * 1972-09-12 1974-05-08

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4947520A (en) * 1972-09-12 1974-05-08

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63227521A (en) * 1987-02-26 1988-09-21 アルザ・コーポレーション Skin penetration accelerator composition using sucrose ester

Similar Documents

Publication Publication Date Title
DE60018372T2 (en) ORAL COMPOSITION AS MICROEMULSION OF SILYBIN
AU686123B2 (en) Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
KR900000077A (en) Sustained Release Formulations Containing Constant Water
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
GR3017411T3 (en) Production process of microspheres.
DK280884A (en) GALENIC PREPARATIONS FOR ORAL ANTIDIABETICS AND PROCEDURES FOR THEIR PREPARATION
ES8403024A1 (en) Pharmaceutical preparations.
CA2104461A1 (en) Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
DK281184A (en) GALENIC PREPARATIONS FOR ORAL ANTIDIABETICS AND PROCEDURES FOR THEIR PREPARATION
SE8803221D0 (en) WATER SOLUBLE MONOESTERS AS SOLUBILIZERS FOR PHARMACOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL EXCIPIENTS
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
IE781032L (en) Pharmaceutical compositions
KR20020000316A (en) Alprostadil-containing composition for external application
GR3003355T3 (en) Nicorandil-containing preparation for injection
IE821796L (en) Waterless thixotropic composition
DE3764111D1 (en) COMBINATION OF MEDICINAL PRODUCTS.
JPS5679626A (en) Semi-solid medicine
KR880002506A (en) Percutaneous composition
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
JPS53139716A (en) Pharmaceutical preparation of stable prostaglandine
JPS5616409A (en) Gamma-oryzanol pharmaceutical preparation
EP0238198A3 (en) Method of modifying the lipid structure function and expression of cell membranes and pharmaceutical compositions for use therein
JPS5612309A (en) Oral drug containing ubidecarenone
AU7338587A (en) Pharmaceutical compositions of furosemide, piretanide or lemidosul in a fatty acid alkanolamide base
JPS56110614A (en) External anti-inflammatory and analgesic drug